- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1440
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
ASK1 inhibition: a therapeutic strategy with multi-system benefits ; volume:98 ; number:3 ; day:14 ; month:2 ; year:2020 ; pages:335-348 ; date:3.2020
Journal of molecular medicine ; 98, Heft 3 (14.2.2020), 335-348, 3.2020
- Creator
-
Ogier, Jacqueline M.
Nayagam, Bryony A.
Lockhart, Paul J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00109-020-01878-y
- URN
-
urn:nbn:de:101:1-2020060419562955616382
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ogier, Jacqueline M.
- Nayagam, Bryony A.
- Lockhart, Paul J.
- SpringerLink (Online service)
Other Objects (12)
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma
Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production — promising therapeutic strategy
AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Multi-system endocrine disruption
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma
Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production — promising therapeutic strategy
AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Multi-system endocrine disruption
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma
Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production — promising therapeutic strategy
AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Braun „Multisystem K 1000“
Multi-system endocrine disruption
Braun „Multisystem K 1000“